> Tsumura and Dainippon Pharmaceutical have returned the development and marketing rights to the hypertension drug lercanidipine hydrochloride back to Italy's Recordati. Report
> The FDA has announced a voluntary recall of the infant oral meds made by Perrigo. Pain and cough relief medications distributed with a 1.6ML syringe were recalled because the syringe was not properly marked for dispensing small doses of the treatments. Release
> BioMarin Pharmaceutical of Novato, California, has filed an NDA for Orapred ODT, new formulation of prednisolone that is billed as "convenient and easy to administer." Release
> India's Wockhardt has received FDA permission to market a copycat form of GSK's Ceftin in the US. Story
> Princeton, New Jersey-based Pharmacopeia has raised $8.47 million in a private placement of stock. Release
> UCB Japan and Daiichi have reinforced their marketing pact on Zyrtec. Story
And Finally… Researchers say that Vitamin E has simply failed to live up to its promise to prevent illness. Feature